Locations:
Search IconSearch
December 15, 2016/Cancer/News & Insight

Toward Better Cancer Care at Lower Cost

Cleveland Clinic Cancer Center joins Oncology Care Model initiative

cancer-care_650x450

Cleveland Clinic Cancer Center has been selected by the Centers for Medicare and Medicaid Services (CMS) Innovation Center to participate in its Oncology Care Model (OCM) program, which aims to transform cancer care by improving quality and efficiency.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The OCM program’s goals are to provide higher-quality, more coordinated oncology care at the same or lower cost to Medicare, using performance-based payment incentives.

“The OCM encourages greater collaboration and information-sharing so that cancer patients get the care they need,” said Health and Human Services Secretary Sylvia M. Burwell. “This patient-centered care model furthers the goal of the Vice President’s Cancer Moonshot to improve coordination, care and outcomes while spending dollars more wisely.”

The nearly 200 oncology practices participating in the five-year OCM will provide treatment that follows nationally recognized clinical guidelines for chemotherapy, with an emphasis on patient-centered care and evidence-based, shared medical decision-making. They will provide enhanced services to help patients receive timely, coordinated treatment. Many of these practice philosophies are already embedded in the care provided by Cleveland Clinic Cancer Center.

These enhanced services may include:

  • Coordinating appointments with providers to ensure timely delivery of diagnostic and treatment services
  • Providing 24/7 access to care when needed
  • Arranging for diagnostic scans and follow-up consultations with other members of the medical team, such as surgeons, radiation oncologists and other specialists
  • Ensuring that imaging data and test results are available in advance of patient appointments
  • Providing access to additional patient resources, such as support groups, pain management services and clinical trials.

Advertisement

In June 2016, nearly 50 Cleveland Clinic Cancer Center professionals from various disciplines gathered to talk about the OCM. “There was a lot of discussion around opportunities to improve the care we provide, as well as how to deliver cost-efficient care emphasizing the multidisciplinary approach,” says Clinical Social Work Supervisor Christa Poole, MSSA, LISW-S.

The OCM aligns with Cleveland Clinic Cancer Center’s overall strategic direction and ongoing efforts to transform and improve cancer care.

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad